Articles with keyword checkpoint inhibitors
-
Immune checkpoint inhibitors in the treatment of cervical cancer: literature review
O.A. Pardabekova
cervical cancer, immunotherapy, immune checkpoint inhibitors, pd-1,
-
Neoadjuvant anti PD-1 / PD-L1 immune checkpoint inhibitors in locall y advanced gastric cancer with microsatellite insta bility
A.Y. Navmatulya, V.A. Chubenko, S.A. Savchuk, F.R. Almukhametova, P.Y. Tsuprun, A.I. Kuznetsov, G.S. Inusilaev, V.A. Heinstein, K.V. Shelekhova, Е.М. Zykov, B.I. Miroshnikov, V.M. Moiseenko
Gastric cancer, immune checkpoint inhibitors, MSI, microsatellite instability, PD-1, PD-L1, objective response, pathologic response.
-
2018 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE
F.V. Moiseenko, V.M. Moiseyenko
cancer, treatment, immunotherapy, checkpoint inhibitors.
-
Systemic treatment of hepatocellular carcinoma: practical issues and perspectives
V.V. Breder, K.K. Laktionov
hepatocellular carcinoma, multi-kinase inhibitors, checkpoint inhibitors.
-
Is it possible to get survival benefit in advanced malignant tumors? (datA from trials, critical aspects)
A.I. Semenova
urothelial carcinoma, immune checkpoint inhibitors, enfortumab vetodin
-
FUTURE OF SYSTEMIC THERAPY IN ONCOUROLOGY: TARGETED AND IMMUNOTHERAPY
F.V. Moiseenko
immunotherapy, targeted therapy, checkpoint inhibitors, urothelial cancer, renal cell cancer.
-
History of immunotherapy of malignant tumors
M.M. Kramchaninov, V.M. Moiseenko
cancer, solid tumors, antitumour drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors
-
Prospects for the use of small interfering RNAs as inhibitors of immune checkpoints for immunotherapy in oncology
A.A. Bogdanov, V.V. Vysochinskaya, A.A. Kornev, A.K. Emelyanov, An.A. Bogdanov, V.M. Moiseyenko
immunotherapy, adaptive cell therapy, RNA interference, targeted therapy, immune checkpoint inhibitors.
-
Immunotherapy: Neoadjuvant and/or adjuvant? Literature review
N.A. Falaleeva, E.A. Bykova, L.Yu. Grivtsova, A.S. Belokhvostova, A.А. Danilenko, I.S. Pimonova, P.V. Shegai, S.A. Ivanov, A.D. Kaprin
Neoadjuvant immunotherapy, immune checkpoint inhibitors, breast cancer, colorectal cancer, non-small cell lung cancer, nonspecific immunotropic therapy.